0.6661
price down icon0.57%   -0.00385
 
loading
Optinose Inc stock is traded at $0.6661, with a volume of 39,558. It is down -0.57% in the last 24 hours and down -6.28% over the past month. OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
See More
Previous Close:
$0.6699
Open:
$0.67
24h Volume:
39,558
Relative Volume:
0.10
Market Cap:
$101.01M
Revenue:
$70.99M
Net Income/Loss:
$-35.48M
P/E Ratio:
-1.3321
EPS:
-0.5
Net Cash Flow:
$-20.86M
1W Performance:
-11.19%
1M Performance:
-6.28%
6M Performance:
-34.05%
1Y Performance:
-46.72%
1-Day Range:
Value
$0.6612
$0.70
1-Week Range:
Value
$0.65
$0.7568
52-Week Range:
Value
$0.65
$2.10

Optinose Inc Stock (OPTN) Company Profile

Name
Name
Optinose Inc
Name
Phone
267-364-3500
Name
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Name
Employee
132
Name
Twitter
@optinose
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
OPTN's Discussions on Twitter

Optinose Inc Stock (OPTN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-21-22 Resumed Jefferies Buy
Apr-07-21 Resumed RBC Capital Mkts Outperform
Dec-18-19 Initiated Cowen Outperform
Aug-08-18 Initiated Cantor Fitzgerald Overweight

Optinose Inc Stock (OPTN) Latest News

pulisher
Oct 31, 2024

Head to Head Review: OPKO Health (NASDAQ:OPK) vs. OptiNose (NASDAQ:OPTN) - Defense World

Oct 31, 2024
pulisher
Oct 20, 2024

Insiders In OptiNose Left Out From 19% Price Rise After Disposing Stock - Simply Wall St

Oct 20, 2024
pulisher
Oct 19, 2024

Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year - Yahoo Finance

Oct 19, 2024
pulisher
Oct 18, 2024

Rosalind Advisors, Inc. Expands Stake in OptiNose Inc - GuruFocus.com

Oct 18, 2024
pulisher
Oct 17, 2024

Optinose Grants Stock Options to Attract New Talent - MSN

Oct 17, 2024
pulisher
Oct 17, 2024

OptiNose faces potential Nasdaq delisting over share price - Investing.com India

Oct 17, 2024
pulisher
Oct 16, 2024

OptiNose faces potential Nasdaq delisting over share price By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 16, 2024

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 16, 2024
pulisher
Oct 14, 2024

Squarepoint Ops LLC Has $178,000 Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

OptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Optinose Appoints Terry Kohler as Chief Financial Officer - MyChesCo

Oct 09, 2024
pulisher
Oct 08, 2024

OptiNose Names Terry Kohler New CFO with Incentive Grant - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

Optinose names Terry Kohler as new CFO - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

Optinose Names Terry Kohler as CFO - MarketWatch

Oct 07, 2024
pulisher
Oct 07, 2024

Optinose names Terry Kohler as new CFO By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 02, 2024

Keeping an Eye on OptiNose Inc (OPTN) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

XTX Topco Ltd Purchases New Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

2,350,010 Shares in OptiNose, Inc. (NASDAQ:OPTN) Purchased by Stonepine Capital Management LLC - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

OptiNose, Inc. (NASDAQ:OPTN) Shares Acquired by Nantahala Capital Management LLC - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Understanding OPTN’s financial ratios: A beginner’s guide - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Stonepine Capital Management LLC Invests $2.44 Million in OptiNose, Inc. (NASDAQ:OPTN) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

OptiNose stock hits 52-week low at $0.68 amid market challenges By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

OptiNose stock hits 52-week low at $0.68 amid market challenges - Investing.com Canada

Sep 30, 2024
pulisher
Sep 27, 2024

Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch - Simply Wall St

Sep 27, 2024
pulisher
Sep 26, 2024

OptiNose announces board member resignation By Investing.com - Investing.com Canada

Sep 26, 2024
pulisher
Sep 26, 2024

OptiNose announces board member resignation - Investing.com India

Sep 26, 2024
pulisher
Sep 25, 2024

Catherine Owen Departs Optinose Board for CEO Role at Acadia - TipRanks

Sep 25, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Increases Stock Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Increases Position in OptiNose, Inc. (NASDAQ:OPTN) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Quarterly Snapshot: Quick and Current Ratios for OptiNose Inc (OPTN) - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Loss-Making OptiNose, Inc. (NASDAQ:OPTN) Expected To Breakeven In The Medium-Term - Simply Wall St

Sep 23, 2024
pulisher
Sep 22, 2024

Massachusetts Financial Services Co. MA Has $3.04 Million Holdings in OptiNose, Inc. (NASDAQ:OPTN) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

A company insider recently sold 3,226 shares of OptiNose Inc [OPTN]. Should You Sale? - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

OptiNose stock hits 52-week low at $0.8 amid market challenges - Investing.com Australia

Sep 20, 2024
pulisher
Sep 19, 2024

Opthea (OPT): Biopharma Innovator on the Verge of a Wet AMD Treatment Revolution - Insider Monkey

Sep 19, 2024
pulisher
Sep 19, 2024

A company insider recently bought 1,334 shares of Oaktree Specialty Lending Corp [OCSL]. Should You Buy? - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Onto Innovation (NYSE:ONTO) Trading 6.1% Higher - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Mary-Louise Parker understands drama better than anyone else, says director - OCRegister

Sep 19, 2024
pulisher
Sep 19, 2024

OPTN’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

Omni Loop Interview: Bernardo Britto Talks Sci-Fi Drama Starring Mary-Louise Parker & Ayo Edebiri - ComingSoon.net

Sep 19, 2024
pulisher
Sep 19, 2024

Opnova Banks Seed Capital to Tackle Security, IT Automation - SecurityWeek

Sep 19, 2024
pulisher
Sep 19, 2024

OUTsurance Group Full Year 2024 Earnings: EPS: R2.65 (vs R1.90 in FY 2023) - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Opko Health Inc [OPK] Records 50-Day SMA of $1.5088 - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Opnova: IT And Compliance Operations Optimization Company Raises $3.75 Million (Pre-Seed) - Pulse 2.0

Sep 19, 2024
pulisher
Sep 19, 2024

Wondrlab acquires OPA, strengthens position in influencer marketing - Indiantelevision.com

Sep 19, 2024
pulisher
Sep 19, 2024

Ontrak announces 1-for-15 reverse split effective September 23 - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Ontrak, Inc. Announces Reverse Stock Split - The Bakersfield Californian

Sep 19, 2024
pulisher
Sep 19, 2024

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study - PR Newswire

Sep 19, 2024
pulisher
Sep 19, 2024

OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Arizona State Retirement System - Defense World

Sep 19, 2024

Optinose Inc Stock (OPTN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optinose Inc Stock (OPTN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mahmoud Ramy A
Chief Executive Officer
Sep 17 '24
Sale
0.87
4,881
4,246
1,202,097
$12.71
price up icon 1.16%
$113.81
price down icon 1.43%
$87.27
price up icon 1.26%
$58.55
price down icon 0.24%
$120.21
price down icon 0.37%
$11.35
price down icon 0.91%
Cap:     |  Volume (24h):